Düsseldorf, Germany

Harald Greve

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 1.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Dusseldorf, DE (1998 - 2021)
  • Düsseldorf, DE (2021)

Company Filing History:


Years Active: 1998-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Harald Greve in Respiratory Treatments

Introduction

Harald Greve is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of respiratory medicine, particularly through his innovative use of monoterpenes. With a total of 3 patents, Greve's work focuses on enhancing the treatment of bronchopulmonary diseases.

Latest Patents

Greve's latest patents include groundbreaking inventions related to the use of monoterpenes for treating respiratory diseases. One of his notable inventions involves the combined use of at least one systemic monoterpene, which can be administered perorally, alongside a topical respiratory tract therapeutic agent that can be inhaled. This combination aims to provide both prophylactic and therapeutic treatment for bronchopulmonary diseases. The synergistic effect of this combination not only enhances the efficiency of the therapeutic agent but also significantly reduces the required dosage, thereby minimizing potential side effects.

Career Highlights

Throughout his career, Harald Greve has worked with various companies, including Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh and Maria Clementine Martin. His experience in these organizations has contributed to his expertise in developing innovative solutions for respiratory disorders.

Collaborations

Greve has collaborated with notable colleagues such as Rainer Greve and Anna-Maria Vestweber. Their combined efforts have further advanced the research and development of effective treatments for respiratory conditions.

Conclusion

Harald Greve's innovative work in the field of respiratory medicine showcases the potential of monoterpenes in enhancing treatment efficacy. His contributions are paving the way for improved therapeutic options for patients suffering from bronchopulmonary diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…